Background Growing recognition of the importance of involving patients in preference-driven healthcare decisions has highlighted the need to develop practical strategies to implement patient-centered shared decisionmaking. The use of tabular balance sheets to support clinical decision-making is well established. More recent evidence suggests that graphic, interactive decision dashboards can help people derive deeper a understanding of information within a specific decision context. We therefore conducted a non-randomized trial comparing the effects of adding an interactive dashboard to a static tabular balance sheet on patient decision-making. Methods The study population consisted of members of the ResearchMatch registry who volunteered to participate in a study of medical decision-making. Two separate surveys were conducted: one in the control group and one in the intervention group. All participants were instructed to imagine they were newly diagnosed with a chronic illness and were asked to choose between three hypothetical drug treatments, which varied with regard to effectiveness, side effects, and out-of-pocket cost. Both groups made an initial treatment choice after reviewing a balance sheet. After a brief ''washout'' period, members of the control group made a second treatment choice after reviewing the balance sheet again, while intervention group members made a second treatment choice after reviewing an interactive decision dashboard containing the same information. After both choices, participants rated their degree of confidence in their choice on a 1 to 10 scale. Results Members of the dashboard intervention group were more likely to change their choice of preferred drug (10.2 versus 7.5 %; p = 0.054) and had a larger increase in decision confidence than the control group (0.67 versus 0.075; p \ 0.03). There were no statistically significant between-group differences in decisional conflict or decision aid acceptability. Conclusion These findings suggest that clinical decision dashboards may be an effective point-of-care decisionsupport tool. Further research to explore this possibility is warranted.
Introduction
Growing recognition of the importance of involving patients in preference-driven healthcare decisions has highlighted the need to develop practical strategies to Electronic supplementary material The online version of this article (doi:10.1007/s40271-015-0111-6) contains supplementary material, which is available to authorized users. implement patient-centered decision-making. Proposed strategies include better ways to provide patients with the information needed to make an informed decision, improved doctor-patient communication methods, and comprehensive decision aids that include both pertinent information and decision-making guidance. Of these, decision aids have received the most attention. Research to date has found that patient decision aids increase patients' knowledge, lower decisional conflict, increase patient involvement in the decision-making process, and promote decisions that are more consistent with patient preferences [1] . Their effects on patient care, however, have been limited because of difficulty implementing them in routine practice settings [2] [3] [4] .
These results have sparked interest in decision-support interventions designed specifically to augment regular doctor-patient interactions at the point of care [5] [6] [7] . Such interventions should make patients aware that several options exist, provide information about the options' advantages and disadvantages, and help patients choose which option they prefer [6] . This approach is potentially capable of overcoming many of the barriers that have impeded the implementation of decision aids [2] . Preliminary evidence supporting this approach exists in the context of medication treatment for patients with type 2 diabetes, and additional studies are underway [8] [9] [10] .
Research in the field of information visualization has shown that graphic, interactive information displays can help people derive a deeper understanding of information within a specific decision context [11, 12] . These advances have led to increasing interest in the use of visual information displays to support decision-making [11] [12] [13] . One of the first products of these activities is the computerbased, interactive decision dashboard. A decision dashboard is ''a visual display of the most important information needed to achieve one or more objectives; consolidated and arranged on a single screen so the information can be monitored at a glance'' [14] . Decision dashboards have been widely adopted as business intelligence tools to help managers and other decision makers quickly and easily access decision-related information and incorporate it into their decision-making processes [15, 16] . These findings suggest that decision dashboards can effectively help people establish their decision-making priorities and make any preference-based trade-offs between decision options needed to make a decision.
In a previous study, we found that an interactive decision-making dashboard could be used to inform medical decisions, was well received by a volunteer sample, augmented the understanding of the information presented, and helped users identify and make the key trade-offs involved in making a treatment choice [17] . That initial study was, however, limited by a small sample size and lack of a control group. The goal of the larger study presented here was to continue this line of investigation by determining whether addition of an interactive decision dashboard to a static tabular balance sheet changes patients' decisions or confidence in their choice of the preferred decision option.
Methods

Study Population
The study population consisted of members of the ResearchMatch panel. ResearchMatch is a national registry of people in the USA who have volunteered to be contacted about clinical research studies. It is maintained by the National Institutes of Health (NIH) Clinical Translational Science Award Consortium [18] . Panel members were eligible for the study if they were 35 years of age or older and had no reported health conditions. Brief notices containing a brief description of the study were sent to 1,781 panel members. Those who indicated interest in the study were then invited to participate and were sent a link to the online study survey.
Study Intervention
Two separate surveys were conducted: one in the control group and one in the intervention group. All participants were instructed to imagine being diagnosed with a chronic illness that impedes their daily activities. They were then asked to choose between three hypothetical treatmentsDrug A, Drug B, and Drug C-which varied with regard to effectiveness, side effects, and out-of-pocket cost. Effectiveness was divided into controlling symptoms and halting disease progression. Side effects were divided into two categories: serious and common. Out-of-pocket cost was defined as the monthly direct cost to the patient. A copy of the survey is included in the Electronic Supplementary Material.
After reading the introduction, participants in both groups examined the balance sheet shown in Table 1 . They were then asked to choose a preferred treatment option and to indicate how confident they were about their choice on a scale from 1 (very unsure) to 10 (very sure). After making their first treatment choice, the study participants answered a series of questions regarding their demographic characteristics, including age, racial and ethnic background, household income, and education level. They then completed the subjective numeracy scale and the Chew health literacy question, which are validated measures of perceived health numeracy and subjective health literacy, respectively [19, 20] . Following this ''washout'' period, control group participants were shown the balance sheet for a second time and the intervention group participants interacted with a clinical decision dashboard. After this second review of information comparing the three treatment choices, both groups were then asked to again select a preferred treatment choice and to indicate how sure they were of their choice, using the same 1 to 10 scale as before.
After indicating their revised preferred treatment, all study participants completed the decisional conflict scale and evaluated the acceptability of the decision aid [21] . We evaluated acceptability by using questions regarding the helpfulness and clarity of the information presented and the likelihood of participants recommending the decision aid to others. The questions and response scales used are summarized in Table 3 .
The main screen of the clinical decision dashboard is shown in Fig. 1 . Its design is based on the prototype used in a prior study [17] . It consisted of five graphs, each showing a single drug attribute, using the same data as those contained in the balance sheet. A different color was used to represent each drug treatment option uniformly throughout the dashboard. Buttons for additional information were provided under each bar graph. Using a series of checkboxes, study participants had the option of displaying each drug separately or in any combination. The dashboard was created using N2, a content-management system 
Statistical Analysis
Our primary study outcomes were differences in the participants' preferred treatment options and confidence in their treatment choices between the first and second decision points. We hypothesized that use of the dashboard would affect the options preferred and would increase subjects' decision confidence. Secondary outcomes included the time needed to complete the study, decisional conflict, and decision aid acceptability. We used standard descriptive statistics to summarize the characteristics of the study population, preferred treatment choices, decision confidence, and decisional conflict. Extreme outliers, defined as values greater than ten times larger than the upper quartile plus three times the interquartile range of minutes spent on the website, were excluded to minimize errors due to users leaving the 
Results
Participation rates among panel members invited to join the study were 51.0 % in the control group and 31.7 % in the dashboard group. This difference was statistically significant (p = 0.002). The characteristics of the study population are summarized in Table 2 . Seven subjects (five in the control group and two in the dashboard group) did not provide demographic information and are not included in this analysis. The study sample consisted of mostly white and non-Hispanic females who had obtained post-graduate degrees, had an annual household income of greater than $100,000, and had good to excellent subjective numeracy and health literacy. The intervention group was significantly older than the control group (p = 0.036). The two study groups did not differ otherwise. Study results are summarized in Table 3 . The most commonly preferred treatment was Drug A, followed by Drug B and Drug C for both the dashboard group and the control group. Members of the dashboard group were more likely to change their choice of preferred drug (10.2 versus 7.5 %, respectively; p = 0.054). The dashboard group had a larger increase in decision confidence than the control group (0.67 versus 0.075; p \ 0.03). There was no association between age and change in decision confidence score (p = 0.68). There were also no significant differences between the two groups in time spent, decisional conflict, decision aid clarity, helpfulness, or likelihood of recommendation to a friend. The reliabilities of the decisional conflict scale and the user evaluation questionnaire, as measured by Cronbach's alpha, were 0.89 and 0.72, respectively.
Discussion and Conclusion
Our study provides moderate evidence that users of a clinical decision dashboard in addition to a tabular option summary are more confident in their choice of a preferred treatment than users of a static, non-interactive tabular display alone. The results also provide weak evidence that table-plus-dashboard users are more likely to change their initial choice of preferred treatment and to take slightly longer to complete the task. These findings are consistent with our prior study and other research suggesting that dashboards can effectively support decision-making in applied contexts.
The structure of the dashboard provides an explanation for our findings. Decision dashboards provide a visual summary of decision-related information displayed in a single view, make extensive use of graphical information displays, and include features that allow users to easily interact with and explore the information being presented. They facilitate the understanding of the relative advantages and disadvantages of decision alternatives by presenting comparative information in a structured format, reducing the cognitive effort required by actively engaging welldeveloped human visual capabilities that help people process and understand information, highlighting factors that merit consideration, and providing information in a nonlinear format to facilitate its incorporation into decisionmaking deliberations [11, 13, [24] [25] [26] [27] [28] [29] [30] [31] . Additionally, because dashboards allow users to control the extent and the content of information displayed, they provide a means for users to self-regulate information exposure and avoid overload in the face of large amounts of information [24] .
Our findings are subject to several limitations. The first is that our data were generated by a group of volunteers presented with a hypothetical decision scenario rather than patients facing an actual health care decision. Although this design was appropriate for an early-phase developmental study, it cannot address the comparative effectiveness of clinical dashboards versus balance sheets when used as a point-of-care tool in actual practice. In addition, our study sample was highly educated, numerate, and literate, and the participation rate was significantly lower in the dashboard group than in the control group.
Despite these limitations, the results of this early-phase study indicate that the combined use of a tabular information display and a decision dashboard may be better than a tabular display alone in supporting patient-centered, shared clinical decision-making. The most likely mechanism for this effect is enabling patients to better define their decision-related preferences and priorities. Further research to explore the effectiveness of dashboard-based decisionsupport interventions on clinical decision-making, doctorpatient communication, and patient involvement in decision-making is warranted.
